12 January 2021
Baker McKenzie has successfully acted for HMS on its acquisition of Lorica Health, one of the largest payment accuracy solutions providers in Australia.
Baker McKenzie's lead partner, Ben McLaughlin, stated: "We were delighted to act for our US client, HMS, a leader in healthtech, on its acquisition of Lorica Health, based here in Australia. This strategic acquisition bolsters our client's capabilities in one of the world's fastest growing regions for healthcare analytics and technology services."
HMS is a US healthcare analytics and technology company that helps healthcare organizations reduce costs and improve health outcomes. Traded on NASDAQ (HMSY), HMS has over 3,100 employees, with 30+ offices across the US and in Hyderabad, India.
Lorica Health is an Australian healthtech company, with proven experience working across both the Australian public and private sectors to implement advanced, policy-aligned analytics software and policy advice. The use of sophisticated data analytics identifies fraud, abuse, waste and errors, and is expanding to detect and discourage low-quality and low-value care delivery. This ultimately improves the efficiency and fairness of healthcare systems, leading to better health outcomes for all.
Ben led a Baker McKenzie team comprising Kate Jefferson, Madeleine McIntosh, Lewis Assness, Toby Patten, Michael Michalandos, and Lucienne Gleeson.
Clayton Utz acted for the sellers.
For further information, please contact:
Ben McLaughlin, Partner, Baker & McKenzie
Ben.McLaughlin@bakermckenzie.com
